Dr. Prasad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2925 Debarr Rd
Ste D350
Anchorage, AK 99508Phone+1 907-276-3676Fax+1 907-276-3679
Summary
- Dr. Madhu Prasad is a general surgeon in Detroit, MI and is affiliated with Providence Alaska Medical Center. He received his medical degree from Wayne State University School of Medicine and has been in practice 27 years. He specializes in surgical oncology (other than breast) and is experienced in esophageal cancer, gastric cancer, head and neck oncology and microvascular reconstruction, surgical oncology (non-breast), and sarcomas.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Surgery, 1990 - 1997
Wayne State University School of MedicineClass of 1990
Certifications & Licensure
OR State Medical License 2000 - Present
AK State Medical License 2014 - 2024
MI State Medical License 1994 - 2016
MA State Medical License 1997 - 2007- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 51 citationsAnticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in ChemotherapyAamer Qazi, Jagannath Pal, Ma'in Y. Maitah, Mariateresa Fulciniti, Dheeraj Pelluru
Translational Oncology. 2010-12-01 - 48 citationsSulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cellsChristopher S. Bryant, Sanjeev Kumar, Sreedhar Chamala, Jay P. Shah, Jagannath Pal
Molecular Cancer. 2010-03-02 - 72 citationsRitonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.Sanjeev Kumar, Christopher S. Bryant, Sreedhar Chamala, Aamer Qazi, Shelly Seward
Molecular Cancer. 2009-04-22
Press Mentions
Madhu Prasad, MD, a Surgical Oncologist with Far North SurgeryNovember 1st, 2019- Why a Became a Surgeon, and Then a Medical DirectorJune 13th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
